Panacea Acquisition II prices $150M SPAC IPO in biotech space (NYSE:NUVB)

The latest SPAC from Panacea Acquisition (NYSE:NUVB), who took preclinical stage oncology company Nuvation Bio through a reverse merger, will begin trading Wednesday, April 7, after staging…
Read More